Home »
Intravenous immune globulin (IVIG)—a common treatment for multisystem inflammatory syndrome in children (MIS-C)—likely works by depleting immune cells called neutrophils, according …
A recent study from Thailand, published in the journal Lancet Infectious Diseases, highlights a rather low degree of neutralization-afforded protection …
Developing a viable vaccine against dengue virus has proved difficult because the pathogen is actually four different virus types, or …
A new preprint study posted to the medRxiv* server shows an AstraZeneca’s ChAdOx1-nCov-19 and Pfizer/BioNTech BNT162b2 COVID-19 vaccine combination is …
Several vaccines have been developed, approved and rolled out to prevent coronavirus disease 2019 (COVID-19), caused by severe acute respiratory …
A research group from the U.S. demonstrated the practicality of a spike display system in order to accelerate vaccine design, …
Scientists in Colombia have identified a new highly divergent SARS-CoV-2 lineage with Spike substitutions L249S and E484K. These same mutations …
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 …
Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people …
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may …
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein …
By Shelley Farrar, MSc, BSc Fluorescence Microscopy allows specimens to be studied with high sensitivity and specificity through the use …
Preliminary results of a phase 3, randomized, placebo-controlled clinical trial testing the investigative monoclonal antibody LY-CoV555 in hospitalized COVID-19 patients …
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and the Bill & Melinda Gates Foundation, as part of …
Researchers at the University of Tennessee Health Science Center working with colleagues at MD Anderson Cancer Center in Houston have …
Sweden is testing a population to SARS-CoV-2 antibody People in Sweden are between 20 and 64 years old, have Covid …